Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsNon-Current ReceivablesReceivables - NetReceivables - OtherReceivables RefundsShares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

Evotec SE (EVO) Shares Outstanding (2021 - 2025)

Evotec SE's Shares Outstanding history spans 5 years, with the latest figure at $206.9 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 9.07% to $206.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $206.9 million, a 9.07% increase, with the full-year FY2025 number at $206.9 million, up 9.07% from a year prior.
  • Shares Outstanding hit $206.9 million in Q4 2025 for Evotec SE, up from $189.7 million in the prior quarter.
  • Over the last five years, Shares Outstanding for EVO hit a ceiling of $206.9 million in Q4 2025 and a floor of $180.5 million in Q4 2022.
  • Historically, Shares Outstanding has averaged $194.0 million across 5 years, with a median of $190.6 million in 2023.
  • Biggest five-year swings in Shares Outstanding: dropped 10.64% in 2022 and later increased 9.07% in 2025.
  • Tracing EVO's Shares Outstanding over 5 years: stood at $202.0 million in 2021, then fell by 10.64% to $180.5 million in 2022, then increased by 5.6% to $190.6 million in 2023, then dropped by 0.48% to $189.7 million in 2024, then increased by 9.07% to $206.9 million in 2025.
  • Business Quant data shows Shares Outstanding for EVO at $206.9 million in Q4 2025, $189.7 million in Q4 2024, and $190.6 million in Q4 2023.